Real-world data on the first-line immune checkpoint inhibitors or in combination with chemotherapy in older patients (aged ≥ 75 years) with advanced non-small cell lung cancer
- Resource Type
- Article
- Source
- In
Heliyon 29 February 2024 10(4) - Subject
- Language
- ISSN
- 2405-8440